CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles

Journal of Medical Genetics

Volumn 51, Issue 5, 2014, Pages 309-318

  Pretto, Dalyir I ^a   Mendoza Morales, Guadalupe ^a   Lo, Joyce ^a   Cao, Ru ^c   Hadd, Andrew ^c   Latham, Gary J ^c   Durbin Johnson, Blythe ^a   Hagerman, Randi ^a,b   Tassone, Flora ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ASURAGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA; FMR1 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BLOOD CELL; BRAIN REGION; BRAIN TISSUE; CAPILLARY ELECTROPHORESIS; CEREBELLUM; CGG ALLELE SIZE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DNA METHYLATION; FRONTAL CORTEX; GENE EXPRESSION; GENETIC PARAMETERS; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; LYMPHOCYTE; MALE; MOSAICISM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY; SOUTHERN BLOTTING; TEMPORAL LOBE; WESTERN BLOTTING; FIBROBLAST; FRAGILE X SYNDROME; GENETICS; HETEROZYGOTE; METABOLISM; MUTATION; PRESCHOOL CHILD; TRINUCLEOTIDE REPEAT; YOUNG ADULT;

ADOLESCENT; AGED; ALLELES; CHILD; CHILD, PRESCHOOL; DNA METHYLATION; FIBROBLASTS; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HETEROZYGOTE; HUMANS; MALE; MOSAICISM; MUTATION; TRINUCLEOTIDE REPEAT EXPANSION; YOUNG ADULT;

EID: 84899482856     PISSN: 00222593     EISSN: 14686244     Source Type: Journal    
DOI: 10.1136/jmedgenet-2013-102021     Document Type: Article

References (60)

1. Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 2000;66:6-15.
2. Iwahashi CK, Yasui DH, An HJ, Greco CM, Tassone F, Nannen K, Babineau B, Lebrilla CB, Hagerman RJ, Hagerman PJ. Protein composition of the intranuclear inclusions of FXTAS. Brain 2006;129(Pt 1):256-71.
3. Sellier C, Rau F, Liu Y, Tassone F, Hukema RK, Gattoni R, Schneider A, Richard S, Willemsen R, Elliott DJ, Hagerman PJ, Charlet-Berguerand N. Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. EMBO J 2010;29:1248-61.
4. Sellier C, Freyermuth F, Tabet R, Tran T, He F, Ruffenach F, Alunni V, Moine H, Thibault C, Page A, Tassone F, Willemsen R, Disney MD, Hagerman PJ, Todd PK, Charlet-Berguerand N. Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor/ataxia syndrome. Cell Rep 2013;3:869-80.
5. Pearson CE. Repeat associated non-ATG translation initiation: one DNA, two transcripts, seven reading frames, potentially nine toxic entities! PLoS Genet 2011;7:e1002018.
6. Todd PK, Oh SY, Krans A, He F, Sellier C, Frazer M, Renoux AJ, Chen KC, Scaglione KM, Basrur V, Elenitoba-Johnson K, Vonsattel JP, Louis ED, Sutton MA, Taylor JP, Mills RE, Charlet-Berguerand N, Paulson HL. CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron 2013;78:440-55.
7. Primerano B, Tassone F, Hagerman RJ, Hagerman P, Amaldi F, Bagni C. Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. RNA 2002;8:1482-8.
8. Peprah E, He W, Allen E, Oliver T, Boyne A, Sherman SL. Examination of FMR1 transcript and protein levels among 74 premutation carriers. J Hum Genet 2010;55:66-8.
9. Kenneson A, Warren ST. The female and the fragile X reviewed. Semin Reprod Med 2001;19:159-65.
10. Hagerman R, Hagerman P. Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. Lancet Neurol 2013;12:786-98.
11. Leehey MA, Hagerman PJ. Fragile X-associated tremor/ataxia syndrome. Handb Clin Neurol 2012;103:373-86.
12. Tassone F, Hagerman RJ, Loesch DZ, Lachiewicz A, Taylor AK, Hagerman PJ. Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am J Med Genet 2000;94:232-6.
13. Aziz M, Stathopulu E, Callias M, Taylor C, Turk J, Oostra B, Willemsen R, Patton M. Clinical features of boys with fragile X premutations and intermediate alleles. Am J Med Genet B Neuropsychiatr Genet 2003;121B:119-27.
14. Farzin F, Perry H, Hessl D, Loesch D, Cohen J, Bacalman S, Gane L, Tassone F, Hagerman P, Hagerman R. Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation. J Dev Behav Pediatr 2006;27(2 Suppl):S137-144.
15. Bailey DB Jr., Raspa M, Olmsted M, Holiday DB. Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey. Am J Med Genet A 2008;146A:2060-9.
16. Goodrich-Hunsaker NJ, Wong LM, McLennan Y, Tassone F, Harvey D, Rivera SM, Simon TJ. Adult Female Fragile X Premutation Carriers Exhibit Age- and CGG Repeat Length-Related Impairments on an Attentionally Based Enumeration Task. Front Hum Neurosci 2011;5:63.
17. Goodrich-Hunsaker NJ, Wong LM, McLennan Y, Tassone F, Harvey D, Rivera SM, Simon TJ. Enhanced manual and oral motor reaction time in young adult female fragile X premutation carriers. J Int Neuropsychol Soc 2011;17:746-50.
18. Goodrich-Hunsaker NJ, Wong LM, McLennan Y, Srivastava S, Tassone F, Harvey D, Rivera SM, Simon TJ. Young adult female fragile X premutation carriers show ageand genetically-modulated cognitive impairments. Brain Cogn 2011;75:255-60.
19. Chonchaiya W, Au J, Schneider A, Hessl D, Harris SW, Laird M, Mu Y, Tassone F, Nguyen DV, Hagerman RJ. Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder. Hum Genet 2012;131:581-9.
20. Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009;360:606-14.
21. Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, Paquin JJ, Yadav-Shah M, Sherman SL. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 2005;20:402-12.
22. Winarni TI, Chonchaiya W, Sumekar TA, Ashwood P, Morales GM, Tassone F, Nguyen DV, Faradz SM, Van de Water J, Cook K, Hamlin A, Mu Y, Hagerman PJ, Hagerman RJ. Immune-mediated disorders among women carriers of fragile X premutation alleles. Am J Med Genet A 2012;158A:2473-81.
23. Jacquemont S, Hagerman RJ, Leehey MA, Hall DA, Levine RA, Brunberg JA, Zhang L, Jardini T, Gane LW, Harris SW, Herman K, Grigsby J, Greco CM, Berry-Kravis E, Tassone F, Hagerman PJ. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 2004;291:460-9.
24. Tassone F, Berry-Kravis EM. The Fragile X-Associated Tremor Ataxia Syndrome (FXTAS). Springer Science+Business Media, 2010.
25. Tassone F, Hagerman RJ, Gane LW, Taylor AK. Strong similarities of the FMR1 mutation in multiple tissues: postmortem studies of a male with a full mutation and a male carrier of a premutation. Am J Med Genet 1999;84:240-4.
26. Nolin SL, Houck GE Jr., Gargano AD, Blumstein H, Dobkin CS, Brown WT. FMR1 CGG-repeat instability in single sperm and lymphocytes of fragile-X premutation males. Am J Hum Genet 1999;65:680-8.
27. Lokanga RA, Entezam A, Kumari D, Yudkin D, Qin M, Smith CB, Usdin K. Somatic expansion in mouse and human carriers of fragile X premutation alleles. Hum Mutat 2013;34:157-66.
28. Lokanga R, Zhao XN, Usdin K. The Mismatch Repair Protein MSH2 is Rate-Limiting for Repeat Expansion in a Fragile X Premutation Mouse Model. Hum Mutat 2014;35:129-36.
29. Wohrle D, Hennig I, Vogel W, Steinbach P. Mitotic stability of fragile X mutations in differentiated cells indicates early post-conceptional trinucleotide repeat expansion. Nat Genet 1993;4:140-2.
30. Glaser D, Wohrle D, Salat U, Vogel W, Steinbach P. Mitotic behavior of expanded CGG repeats studied on cultured cells: further evidence for methylation-mediated triplet repeat stability in fragile X syndrome. Am J Med Genet 1999;84:226-8.
31. Wohrle D, Salat U, Glaser D, Mucke J, Meisel-Stosiek M, Schindler D, Vogel W, Steinbach P. Unusual mutations in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats. J Med Genet 1998;35:103-11.
32. Burman RW, Popovich BW, Jacky PB, Turker MS. Fully expanded FMR1 CGG repeats exhibit a length- and differentiation-dependent instability in cell hybrids that is independent of DNA methylation. Hum Mol Genet 1999;8:2293-302.
33. Wohrle D, Salat U, Hameister H, Vogel W, Steinbach P. Demethylation, reactivation, and destabilization of human fragile X full-mutation alleles in mouse embryocarcinoma cells. Am J Hum Genet 2001;69:504-15.
34. Tassone F, Longshore J, Zunich J, Steinbach P, Salat U, Taylor AK. Tissue-specific methylation differences in a fragile X premutation carrier. Clin Genet 1999;55:346-51.
35. Allingham-Hawkins DJ, Brown CA, Babul R, Chitayat D, Krekewich K, Humphries T, Ray PN, Teshima IE. Tissue-specific methylation differences and cognitive function in fragile X premutation females. Am J Med Genet 1996;64:329-33.
36. Chen L, Hadd AG, Sah S, Houghton JF, Filipovic-Sadic S, Zhang W, Hagerman PJ, Tassone F, Latham GJ. High-resolution methylation polymerase chain reaction for fragile X analysis: evidence for novel FMR1 methylation patterns undetected in Southern blot analyses. Genet Med 2011;13:528-38.
37. Tassone F, Pan R, Amiri K, Taylor AK, Hagerman PJ. A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J Mol Diagn 2008;10:43-9.
38. Filipovic-Sadic S, Sah S, Chen L, Krosting J, Sekinger E, Zhang W, Hagerman PJ, Stenzel TT, Hadd AG, Latham GJ, Tassone F. A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome. Clin Chem 2010;56:399-408.
39. Yrigollen CM, Durbin-Johnson B, Gane L, Nelson DL, Hagerman R, Hagerman PJ, Tassone F. AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome. Genet Med 2012;14:729-36.
40. Yrigollen CM, Tassone F, Durbin-Johnson B. The role of AGG interruptions in the transcription of FMR1 premutation alleles. PLoS One 2011;6:e21728.
41. Wechsler D. Wechsler Adult Intelligence Scale 3rd Edition (WAIS-III). San Antonio, TX, New York: Psychological Corporation, 1997.
42. Wechsler D. Wechsler Adult Intelligence Scale 4th Edition (WAIS-IV). New York: Psychological Corporation, 2008.
43. Wechsler D. Wechsler Memory Scale-Third Edition (WMS-III). New York: Psychological Corporation, 2003.
44. Wechsler D. Wechsler Memory Scale-Fourth Edition (WMS-IV). New York: Psychological Corporation, 2009.
45. Mullen EM. Mullen Scales of Early Learning. Circle Pines, MN: American Guidance Services, Inc, 1995.
46. Derogatis LR. Symptom Checklist-90-R (SCL-90-R): Administration, Scoring, and Procedures Manual. Minneapolis: National Computer Systems, 1994.
47. Lord C, Rutter M, Goode S, Heemsbergen J, Jordan H, Mawhood L, Schopler E. Autism diagnostic observation schedule: a standardized observation of communicative and social behavior. J Autism Dev Disord 1989;19:185-212.
48. Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994;24:659-85.
49. Sparrow SS, Cicchetti DV, Balla DA. Vineland apdaptive behaior scales. 2nd edn. Circle Pines: AGS Publishing, 2005.
50. Swanson JM, Kraemer HC, Hinshaw SP. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adloesc Psychiatry 2001;40:168-79.
51. Allen EG, Sherman S, Abramowitz A, Leslie M, Novak G, Rusin M, Scott E, Letz R. Examination of the effect of the polymorphic CGG repeat in the FMR1 gene on cognitive performance. Behav Genet 2005;35:435-45.
52. Malter HE, Iber JC, Willemsen R, de GraaffE, Tarleton JC, Leisti J, Warren ST, Oostra BA. Characterization of the full fragile X syndrome mutation in fetal gametes. Nat Genet 1997;15:165-9.
53. Devys D, Biancalana V, Rousseau F, Boue J, Mandel JL, Oberle I. Analysis of full fragile X mutations in fetal tissues and monozygotic twins indicate that abnormal methylation and somatic heterogeneity are established early in development. Am J Med Genet 1992;43:208-16.
54. Coffee B, Zhang F, Warren ST, Reines D. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nature Genetics 1999;22:98-101.
55. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 1991;66:817-22.
56. Verheij C, Bakker CE, de GraaffE, Keulemans J, Willemsen R, Verkerk AJ, Galjaard H, Reuser AJ, Hoogeveen AT, Oostra BA. Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature 1993;363:722-4.
57. Primerano B, Tassone F, Hagerman RJ, Hagerman PJ, Amaldi F, Bagni C. Reduced FMR1 mRNA translation efficiency in Fragile X patients with premutations. RNA 2002;8:1482-8.
58. Martorell L, Monckton DG, Gamez J, Johnson KJ, Gich I, Lopez de Munain A, Baiget M. Progression of somatic CTG repeat length heterogeneity in the blood cells of myotonic dystrophy patients. Hum Mol Genet 1998;7:307-12.
59. Martorell L, Martinez JM, Carey N, Johnson K, Baiget M. Comparison of CTG repeat length expansion and clinical progression of myotonic dystrophy over a five year period. J Med Genet 1995;32:593-6.
60. Gilbert SF. Developmental Biology, 6th edn. Sinauer Associats, Inc., 2013.